June 13th 2025
The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule oral therapy for immunological diseases.
A Look at CDMO–Biotech Partnerships and Tackling Complex Technical Challenges (BIO 2024)
October 30th 2024Frontage Laboratories' Marianna Tcherpakov, PhD, director of Business Development, CMC Services, discussed the CDMO’s role in enabling startup biotechs solve complex technical challenges for scale up.
Behind the Headlines: GLP-1 Shortage, Nobel Prize, RNA Editing, and More
October 24th 2024Laks Pernenkil, Brian Feth, and Alex Philippidis go behind the headlines to discuss the impact of recent news, including FDA’s drug shortage list update, Nobel prize winners in microRNA and AI, and a big-potential research win for RNA editing.